Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP3 | Q9NY33 | 3/20 | 0.47 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.47 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.47 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.45 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.44 |
| ▸ | CTSB | P07858 | 2/20 | 0.44 |
| ▸ | TACR1 | P25103 | 1/20 | 0.44 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.43 |
| ▸ | CCKBR | P32239 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30467090 | 0.88 | CAPN1 (0.52) | DPP3NTSR2NTSR1SORT1CAPN1 | |
| SCHEMBL30523243 | 0.83 | CXCR4 (0.54) | NTSR2NTSR1SORT1OPRD1CAPN1 | |
| SCHEMBL30543481 | 0.81 | GLP1R (0.51) | — | |
| SCHEMBL31058451 | 0.79 | CXCR4 (0.52) | NTSR2NTSR1SORT1OPRD1CAPN1 | |
| SCHEMBL32677743 | 0.79 | CXCR4 (0.52) | CAPN1CTSBCXCR4 | |
| SCHEMBL30608572 | 0.78 | CXCL8 (0.54) | CAPN1CTSB | |
| SCHEMBL31347345 | 0.78 | CMA1 (0.37) | OPRD1 | |
| SCHEMBL31058453 | 0.78 | GLP1R (0.55) | — | |
| SCHEMBL31119461 | 0.77 | C5AR1 (0.56) | CXCR4 | |
| SCHEMBL31119468 | 0.77 | C5AR1 (0.56) | CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724472-A2 | GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS | Sun Pharmaceutical Industries Limited (IN) | 2026-04-15 | — | — | EP | disclosed |
| WO-2024252367-A2 | NOVEL GLP-1/GIP DUAL AND GLP-1/GCG DUAL RECEPTOR AGONISTS | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2024-12-12 | — | — | WO | disclosed |